Controversy II: Bioequivalence as an Indicator of Therapeutic Equivalence: Modeling the Theoretic Influence of Bioinequivalence on Single-Dose Drug Effect
- 6 May 1987
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 27 (5) , 342-345
- https://doi.org/10.1002/j.1552-4604.1987.tb03029.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Modeling the pharmacokinetics and pharmacodynamics of trimazosinBiopharmaceutics & Drug Disposition, 1986
- Generic Equivalents: Issues and ConcernsThe Journal of Clinical Pharmacology, 1986
- A Time to Speak Out on Bioequivalence and Therapeutic EquivalenceThe Journal of Clinical Pharmacology, 1986
- Bioequivalence or Therapeutic EquivalenceThe Journal of Clinical Pharmacology, 1986
- Simultaneous pharmacokinetic and pharmacodynamic modelingJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Multiple receptor responses: A new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug: Studies on clonidine in the rat and catJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Studies in Man with a Constant-Rate Infusion of TubocurarineAnaesthesia and Intensive Care, 1979
- Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d‐tubocurarineClinical Pharmacology & Therapeutics, 1979
- Bioavailability, Clinical Effectiveness, and the Public InterestPharmacology, 1972